However, developing a CSP-only malaria vaccine with high efficacy and durability of protection has been hampered by various roadblocks, and identifying additional PE vaccine antigens to augment antisporozoite immunity may be a promising strategy to fortify CSP-based vaccines. This evidence concerns the gene DNAJC5 and malaria.